Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$132.76 USD
+1.43 (1.09%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $132.76 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ABT 132.76 +1.43(1.09%)
Will ABT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ABT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABT
Abbott (ABT) Gains As Market Dips: What You Should Know
Wall Street Analysts See Abbott (ABT) as a Buy: Should You Invest?
ABT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
Abbott (ABT) Stock Sinks As Market Gains: What You Should Know
NVST vs. ABT: Which Stock Should Value Investors Buy Now?
Other News for ABT
Slingshot Bullish appears for ABT after 1.79% move
ABT January 2028 Options Begin Trading
ABT forms 20 Day Moving Average Support on September 12
Bernstein Remains a Buy on Abbott Laboratories (ABT)
Crossed Above 20 Day Moving Average appears for ABT after 2.54% move